Tuxumdon giperstimulyatsiyasi sindromi (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tuxumdon giperstimulyatsiyasi sindromi" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

4^th place

7^th place

2^nd place

3^rd place

1^st place

low place

low place

doi.org

Shmorgun, Doron; Claman, Paul (2011). "The diagnosis and management of ovarian hyperstimulation syndrome". Journal of Obstetrics and Gynaecology Canada 33 (11): 1156–62. doi:10.1016/s1701-2163(16)35085-x. PMID 22082791. Archived from the original on 2015-07-10. https://web.archive.org/web/20150710220407/http://jogc.ca/abstracts/full/201111_SOGCClinicalPracticeGuidelines_1.pdf. Qaraldi: 2015-07-09. Tuxumdon giperstimulyatsiyasi sindromi]]
Humaidan, P.; Kol, S.; Papanikolaou, E. (2011). "GnRH agonist for triggering of final oocyte maturation: time for a change of practice?". Human Reproduction Update 17 (4): 510–24. doi:10.1093/humupd/dmr008. PMID 21450755.
La Marca, A.; Sunkara, S. K. (2013). "Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice". Human Reproduction Update 20 (1): 124–40. doi:10.1093/humupd/dmt037. PMID 24077980.
Youssef, M. A.; Mourad, S. (2016). "Volume expanders for the prevention of ovarian hyperstimulation syndrome". The Cochrane Database of Systematic Reviews 2016 (8): CD001302. doi:10.1002/14651858.CD001302.pub3. PMID 27577848. PMC 9243766. //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=9243766.

Shmorgun, Doron; Claman, Paul (2011). "The diagnosis and management of ovarian hyperstimulation syndrome". Journal of Obstetrics and Gynaecology Canada 33 (11): 1156–62. doi:10.1016/s1701-2163(16)35085-x. PMID 22082791. Archived from the original on 2015-07-10. https://web.archive.org/web/20150710220407/http://jogc.ca/abstracts/full/201111_SOGCClinicalPracticeGuidelines_1.pdf. Qaraldi: 2015-07-09. Tuxumdon giperstimulyatsiyasi sindromi]]
Humaidan, P.; Kol, S.; Papanikolaou, E. (2011). "GnRH agonist for triggering of final oocyte maturation: time for a change of practice?". Human Reproduction Update 17 (4): 510–24. doi:10.1093/humupd/dmr008. PMID 21450755.
La Marca, A.; Sunkara, S. K. (2013). "Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice". Human Reproduction Update 20 (1): 124–40. doi:10.1093/humupd/dmt037. PMID 24077980.
Youssef, M. A.; Mourad, S. (2016). "Volume expanders for the prevention of ovarian hyperstimulation syndrome". The Cochrane Database of Systematic Reviews 2016 (8): CD001302. doi:10.1002/14651858.CD001302.pub3. PMID 27577848. PMC 9243766. //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=9243766.

Ovarian hyperstimulation syndrome Updated by: Linda J. Vorvick and Susan Storck Update. Also reviewed by David Zieve. Date: 7/27/2009

Youssef, M. A.; Mourad, S. (2016). "Volume expanders for the prevention of ovarian hyperstimulation syndrome". The Cochrane Database of Systematic Reviews 2016 (8): CD001302. doi:10.1002/14651858.CD001302.pub3. PMID 27577848. PMC 9243766. //www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=9243766.

Severi, F.M.; Bocchi, C.; Vannuccini, S.; Petraglia, F. (2012). "Ovary and ultrasound: from physiology to disease". Archives of Perinatal Medicine 18 (1): 7–19. http://www.ptmp.com.pl/archives/apm/18-1/APM181-1-Severi.pdf. Qaraldi: 2015-07-09. Tuxumdon giperstimulyatsiyasi sindromi]]